Analyst targets remain bullish but widely dispersed

Goldman Sachs reportedly lifted its CRWV price target from $121 to $139 while maintaining Neutral. Other cited targets include Truist at $165 and Barclays at $180, while consensus estimates range from approximately $141.90 to $144.46, keeping valuation disagreement central to sentiment.